Literature DB >> 9180156

Effects of bacillus Calmette-Guerin and interferon-alpha-2B on human bladder cancer in vitro.

Y Zhang1, H E Khoo, K Esuvaranathan.   

Abstract

The cytolytic and anti-proliferative effects of bacillus Calmette-Guerin (BCG) and/or interferon-alpha-2b (IFN-alpha-2b) on 5 human bladder carcinoma cell lines, RT4, RT112, MGH, SD and J82, were determined. The cell lines showed different sensitivities to BCG and IFN-alpha-2b. BCG had direct dose-dependent cytolytic and anti-proliferative effects on MGH, J82 and SD (grade 3 cell lines), whereas RT4 and RT112 (grades 1 and 2, respectively) were less sensitive. Surprisingly, higher concentrations of BCG enhanced cell growth of RT4. IFN-alpha-2b also had cytolytic and anti-proliferative effects on all 5 cell lines. Thus, the RT4 and RT112 cell lines that were not sensitive to BCG were highly sensitive to IFN-alpha-2b. A combination of BCG and IFN-alpha-2b had additive anti-proliferative effects on MGH, J82 and RT112. Interleukin-6 (IL-6) and tumor necrosis factor-alpha (TNF-alpha) production by these 5 cell lines was measured after stimulation with BCG and/or IFN-alpha-2b, by ELISA immunoassays. Production of IL-6 and TNF-alpha was significantly increased in MGH and J82 cell lines by the combination of BCG and IFN alpha-2b. The enhanced cytolytic and anti-proliferative effects of the combination of BCG and IFN-alpha-2b may be related to the induction of cytokines.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9180156     DOI: 10.1002/(sici)1097-0215(19970529)71:5<851::aid-ijc25>3.0.co;2-9

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  6 in total

1.  Mycobacterium bovis bacillus Calmette-Guérin (BCG) induces human CC- and CXC-chemokines in vitro and in vivo.

Authors:  Y Luo; X Chen; M A O'Donnell
Journal:  Clin Exp Immunol       Date:  2007-02       Impact factor: 4.330

2.  The CUL4B-miR-372/373-PIK3CA-AKT axis regulates metastasis in bladder cancer.

Authors:  Xiaochen Liu; Jianfeng Cui; Li Gong; Fei Tian; Yangli Shen; Lipeng Chen; Yong Wang; Yangyang Xia; Lei Liu; Xiang Ye; Molin Wang; Guangyi Liu; Baichun Jiang; Changshun Shao; Yongxin Zou; Yaoqin Gong
Journal:  Oncogene       Date:  2020-03-03       Impact factor: 9.867

3.  Mycobacterium bovis bacille Calmette-Guerin-derived extracellular vesicles as an alternative to live BCG immunotherapy.

Authors:  Patrick Gellings; Michelle Galeas-Pena; Lisa A Morici
Journal:  Clin Exp Med       Date:  2022-01-25       Impact factor: 3.984

4.  BCG strain S4-Jena: An early BCG strain is capable to reduce the proliferation of bladder cancer cells by induction of apoptosis.

Authors:  Katja Schwarzer; Martin Foerster; Thomas Steiner; Inge-Marie Hermann; Eberhard Straube
Journal:  Cancer Cell Int       Date:  2010-06-29       Impact factor: 5.722

5.  Bacillus Calmette-Guérin induces rapid gene expression changes in human bladder cancer cell lines that may modulate its survival.

Authors:  Juwita N Rahmat; Kesavan Esuvaranathan; Ratha Mahendran
Journal:  Oncol Lett       Date:  2018-04-11       Impact factor: 2.967

6.  Synergistic Cytotoxic Effects of Ganoderma lucidum and Bacillus Calmette Guérin on Premalignant Urothelial HUC-PC Cells and Its Regulation on Proinflammatory Cytokine Secretion.

Authors:  John Wai-Man Yuen; Mayur-Danny I Gohel; Chi-Fai Ng
Journal:  Evid Based Complement Alternat Med       Date:  2012-08-28       Impact factor: 2.629

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.